We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
欧洲监管机构推荐Itvisma用于成人SMA和Cenrifki用于继发进展型多发性硬化症。了解一次性注射和药片如何填补神经退行性疾病治疗的空白。
